8 results match your criteria: "Peking University National Urological Cancer Center[Affiliation]"
Surg Innov
August 2024
Advent Health Global Robotics Institute, Celebration, FL, USA.
Introduction: Robotic surgery has transformed minimally invasive procedures, offering precision and efficiency. However, the ergonomic aspects of robotic consoles and their impact on surgeon health remain understudied. This review investigates the burden of ergonomics and muscle fatigue among robotic surgeons in China, comparing the findings to a multinational study.
View Article and Find Full Text PDFEur Urol Focus
January 2023
Department of Urology, Peking University First Hospital, Institute of Urology, Peking University. National Urological Cancer Center, Beijing, China. Electronic address:
Background: The KangDuo surgical robot (KD-SR) was recently developed in China.
Objective: To compare the safety and efficacy of the KD-SR versus the da Vinci Si Surgical System (DV-SS-Si) for robot-assisted partial nephrectomy (RAPN).
Design, Setting, And Participants: A double-center prospective randomized controlled noninferiority trial of patients aged 18-75 yr with a suspicion of T1a N0M0 renal cancer (RENAL nephrometry score ≤9) was conducted.
Int Urol Nephrol
March 2023
Department of Urology, Institute of Urology, Peking University First Hospital, Peking University. National Urological Cancer Center, No. 8 Xishiku St, Xicheng District, Beijing, 100034, People's Republic of China.
Purpose: Ureteroplasty with a lingual mucosa graft (LMG) for complex ureteral stricture was reported promising. We aimed to compare outcomes of robotic versus laparoscopic ureteroplasty using a LMG (RU-LMG vs. LU-LMG, respectively).
View Article and Find Full Text PDFUrol J
May 2021
Department of Urology, Peking University First Hospital. Institute of Urology, Peking University. National Urological Cancer Center, Beijing, P.R. China.
Purpose: To evaluate the feasibility and guiding significance in postoperative management of the Whitaker test after complex reconstruction of the upper urinary tract.
Materials And Methods: Patients who underwent complex ureteral reconstruction and received the Whitaker test after surgery between December 2018 and December 2019 were included. We judged it abnormal that the renal pelvis pressure was higher than 22 cmH2O or the pressure difference was greater than 15 cmH2O.
Int Braz J Urol
January 2021
Department of Urology, Peking University First Hospital. Institute of Urology, Peking University National Urological Cancer Center, Beijing, China.
Objectives:: To discuss the feasibility and efficacy of a laparoscopic vessel blocking forceps in laparoscopic inferior vena cava (IVC) thrombectomy (–3).
Materials And Methods:: The patient was secured in a left lateral decubitus position. The surgical field was built with 4-trocar.
Transl Androl Urol
January 2021
Department of Urology, Peking University First Hospital Institute of Urology, Peking University National Urological Cancer Center, Beijing, China.
Background: To evaluate the feasibility and effect of upper urinary tract videourodynamics in complex reconstructed upper urinary tract.
Methods: From January 2016 to December 2018, patients who underwent complex upper urinary tract reconstruction and received upper urinary tract videourodynamics were included in the study. The modified Whitaker test was performed at 3 months after operation.
Urol Int
March 2019
Department of Urology, Peking University First Hospital. Institute of Urology, Peking University. National Urological Cancer Center, Beijing, China.
Objectives: To present our modified laparoscopic partial ureterectomy technique for adult ureteral fibroepithelial polyp (FEP) and initial experience.
Methods: Between August 2009 and October 2017, 22 patients with ureteral FEP underwent modified laparoscopic partial ureterectomy by an experienced surgeon. In our method, a stay suture passing through the upper ureter was fixed to the abdominal wall to keep the ureter from twisting.
Chin Med J (Engl)
April 2015
Institute of Urology, Peking University National Urological Cancer Center, Beijing 100034, China.